Cargando…
P1132: LONG-TERM RESPONSES WITH LONCASTUXIMAB TESIRINE: UPDATED RESULTS FROM LOTIS-2, THE PIVOTAL PHASE 2 STUDY IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA
| Autores principales: | , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431093/ http://dx.doi.org/10.1097/01.HS9.0000971424.40251.1c |
| _version_ | 1785091118129479680 |
|---|---|
| author | Caimi, Paolo F Ai, Weiyun Z Pablo Alderuccio, Juan Ardeshna, Kirit M Hamadani, Mehdi Hess, Brian Kahl, Brad S Radford, John Solh, Melhem Stathis, Anastasios Luigi Zinzani, Pier Wang, Ying Qin, Yajuan Wang, Luqiang Xu, Cindy Carlo-Stella, Carmelo |
| author_facet | Caimi, Paolo F Ai, Weiyun Z Pablo Alderuccio, Juan Ardeshna, Kirit M Hamadani, Mehdi Hess, Brian Kahl, Brad S Radford, John Solh, Melhem Stathis, Anastasios Luigi Zinzani, Pier Wang, Ying Qin, Yajuan Wang, Luqiang Xu, Cindy Carlo-Stella, Carmelo |
| author_sort | Caimi, Paolo F |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10431093 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104310932023-08-17 P1132: LONG-TERM RESPONSES WITH LONCASTUXIMAB TESIRINE: UPDATED RESULTS FROM LOTIS-2, THE PIVOTAL PHASE 2 STUDY IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA Caimi, Paolo F Ai, Weiyun Z Pablo Alderuccio, Juan Ardeshna, Kirit M Hamadani, Mehdi Hess, Brian Kahl, Brad S Radford, John Solh, Melhem Stathis, Anastasios Luigi Zinzani, Pier Wang, Ying Qin, Yajuan Wang, Luqiang Xu, Cindy Carlo-Stella, Carmelo Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10431093/ http://dx.doi.org/10.1097/01.HS9.0000971424.40251.1c Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Caimi, Paolo F Ai, Weiyun Z Pablo Alderuccio, Juan Ardeshna, Kirit M Hamadani, Mehdi Hess, Brian Kahl, Brad S Radford, John Solh, Melhem Stathis, Anastasios Luigi Zinzani, Pier Wang, Ying Qin, Yajuan Wang, Luqiang Xu, Cindy Carlo-Stella, Carmelo P1132: LONG-TERM RESPONSES WITH LONCASTUXIMAB TESIRINE: UPDATED RESULTS FROM LOTIS-2, THE PIVOTAL PHASE 2 STUDY IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA |
| title | P1132: LONG-TERM RESPONSES WITH LONCASTUXIMAB TESIRINE: UPDATED RESULTS FROM LOTIS-2, THE PIVOTAL PHASE 2 STUDY IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA |
| title_full | P1132: LONG-TERM RESPONSES WITH LONCASTUXIMAB TESIRINE: UPDATED RESULTS FROM LOTIS-2, THE PIVOTAL PHASE 2 STUDY IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA |
| title_fullStr | P1132: LONG-TERM RESPONSES WITH LONCASTUXIMAB TESIRINE: UPDATED RESULTS FROM LOTIS-2, THE PIVOTAL PHASE 2 STUDY IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA |
| title_full_unstemmed | P1132: LONG-TERM RESPONSES WITH LONCASTUXIMAB TESIRINE: UPDATED RESULTS FROM LOTIS-2, THE PIVOTAL PHASE 2 STUDY IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA |
| title_short | P1132: LONG-TERM RESPONSES WITH LONCASTUXIMAB TESIRINE: UPDATED RESULTS FROM LOTIS-2, THE PIVOTAL PHASE 2 STUDY IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA |
| title_sort | p1132: long-term responses with loncastuximab tesirine: updated results from lotis-2, the pivotal phase 2 study in patients with relapsed/refractory diffuse large b-cell lymphoma |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431093/ http://dx.doi.org/10.1097/01.HS9.0000971424.40251.1c |
| work_keys_str_mv | AT caimipaolof p1132longtermresponseswithloncastuximabtesirineupdatedresultsfromlotis2thepivotalphase2studyinpatientswithrelapsedrefractorydiffuselargebcelllymphoma AT aiweiyunz p1132longtermresponseswithloncastuximabtesirineupdatedresultsfromlotis2thepivotalphase2studyinpatientswithrelapsedrefractorydiffuselargebcelllymphoma AT pabloalderucciojuan p1132longtermresponseswithloncastuximabtesirineupdatedresultsfromlotis2thepivotalphase2studyinpatientswithrelapsedrefractorydiffuselargebcelllymphoma AT ardeshnakiritm p1132longtermresponseswithloncastuximabtesirineupdatedresultsfromlotis2thepivotalphase2studyinpatientswithrelapsedrefractorydiffuselargebcelllymphoma AT hamadanimehdi p1132longtermresponseswithloncastuximabtesirineupdatedresultsfromlotis2thepivotalphase2studyinpatientswithrelapsedrefractorydiffuselargebcelllymphoma AT hessbrian p1132longtermresponseswithloncastuximabtesirineupdatedresultsfromlotis2thepivotalphase2studyinpatientswithrelapsedrefractorydiffuselargebcelllymphoma AT kahlbrads p1132longtermresponseswithloncastuximabtesirineupdatedresultsfromlotis2thepivotalphase2studyinpatientswithrelapsedrefractorydiffuselargebcelllymphoma AT radfordjohn p1132longtermresponseswithloncastuximabtesirineupdatedresultsfromlotis2thepivotalphase2studyinpatientswithrelapsedrefractorydiffuselargebcelllymphoma AT solhmelhem p1132longtermresponseswithloncastuximabtesirineupdatedresultsfromlotis2thepivotalphase2studyinpatientswithrelapsedrefractorydiffuselargebcelllymphoma AT stathisanastasios p1132longtermresponseswithloncastuximabtesirineupdatedresultsfromlotis2thepivotalphase2studyinpatientswithrelapsedrefractorydiffuselargebcelllymphoma AT luigizinzanipier p1132longtermresponseswithloncastuximabtesirineupdatedresultsfromlotis2thepivotalphase2studyinpatientswithrelapsedrefractorydiffuselargebcelllymphoma AT wangying p1132longtermresponseswithloncastuximabtesirineupdatedresultsfromlotis2thepivotalphase2studyinpatientswithrelapsedrefractorydiffuselargebcelllymphoma AT qinyajuan p1132longtermresponseswithloncastuximabtesirineupdatedresultsfromlotis2thepivotalphase2studyinpatientswithrelapsedrefractorydiffuselargebcelllymphoma AT wangluqiang p1132longtermresponseswithloncastuximabtesirineupdatedresultsfromlotis2thepivotalphase2studyinpatientswithrelapsedrefractorydiffuselargebcelllymphoma AT xucindy p1132longtermresponseswithloncastuximabtesirineupdatedresultsfromlotis2thepivotalphase2studyinpatientswithrelapsedrefractorydiffuselargebcelllymphoma AT carlostellacarmelo p1132longtermresponseswithloncastuximabtesirineupdatedresultsfromlotis2thepivotalphase2studyinpatientswithrelapsedrefractorydiffuselargebcelllymphoma |